Home 2

Supporting individuals with Alzheimer's disease and those that care for them

Dthera Sciences (OTCQB: DTHR) is a publicly traded digital therapeutics company focused on the elderly and individuals with neurodegenerative diseases.

The Alzheimer's Disease Healthcare Crisis

5.7 million Americans are living with Alzheimer’s disease. By 2050, this number is projected to rise to to nearly 14 million

Digital Therapeutics

Digitizing evidence-based cognitive-behavioral therapies and delivering them at scale

Breakthrough Device Designation

DTHR-ALZ is the first product to receive
Breakthrough Device designation from the FDA
for the treatment of Alzheimer’s disease